Aldesleukin Completed Phase 1 Trials for Brain and Central Nervous System Tumors Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00002572Cytotoxic T Cells and Interleukin-2 in Treating Adult Patients With Recurrent Brain Tumors